HHS warns drugmakers that won't give 340B discounts to contract pharmaciesHHS warns drugmakers that won't give 340B discounts to contract pharmaciesHHS warns drugmakers that won't give 340B discounts to contract pharmacies

HHS warns drugmakers that won't give 340B discounts to contract pharmacies

The agency sent warning letters to AstraZeneca, Eli Lilly, Novartis, Novo Nordisk, Sanofi and United Therapeutics. They could face fines of up to $5,000 per overcharge if they don't start following the rules and issue refunds.

from Section Page News - Modern Healthcare https://ift.tt/3eRD0B1